Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04654481 · ClinicalTrials.gov registry record · NA
Study of AffloVest in At-Risk Respiratory Patients During COVID-19 Pandemic
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT04654481 is a NA study that was terminated before completion, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 1 participants.
The verdict
NCT04654481, a NA study, was terminated before completion, sponsored by Icahn School of Medicine at Mount Sinai.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
The purpose of the study is to investigate the addition of high frequency chest wall oscillation (HFCWO) therapy to the prescribed care regimen to support the diaphragm during airway clearance among post-COVID patients with COPD and chronic productive cough as a way to limit the advancement of pulmonary symptoms and need for critical services during recovery from COVID-19.
Interventions
- DEVICE HCFWO
- OTHER Standard Care Plus Monitoring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2021-07-20 |
| Est. Completion | 2021-10-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04654481
The ClinicalTrials.gov registry entry for NCT04654481 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which HCFWO is the first listed.
NCT04654481 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04654481 about?
NCT04654481 is a clinical study titled "Study of AffloVest in At-Risk Respiratory Patients During COVID-19 Pandemic". The purpose of the study is to investigate the addition of high frequency chest wall oscillation (HFCWO) therapy to the prescribed care regimen to support the diaphragm during airway clearance among post-COVID patients with COPD and chronic productive cough as a way to limit the advancement of pulmo...
What is the current status of trial NCT04654481?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2021-07-20. Estimated completion is 2021-10-19.
What interventions are being tested in trial NCT04654481?
The interventions under investigation include: HCFWO (DEVICE), Standard Care Plus Monitoring (OTHER).
Who is sponsoring clinical trial NCT04654481?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.